Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S365000, C514S406000, C514S255040, C514S256000, C514S339000, C548S491000, C548S204000, C548S205000, C548S356100, C546S278100, C544S333000, C544S405000
Reexamination Certificate
active
11182987
ABSTRACT:
A compound, represented by formula (I):wherein A, B, R1, R2, R3, R5, R6, R7, R9, and R10are as defined herein, or an enantiomer, diastereoisomer or tautomer thereof, including a salt, ester or derivative thereof, as an inhibitor of HCV NS5B polymerase.
REFERENCES:
patent: 6448281 (2002-09-01), Beaulieu et al.
patent: 6479508 (2002-11-01), Beaulieu et al.
patent: 6794404 (2004-09-01), Beaulieu et al.
patent: 6841566 (2005-01-01), Beaulieu et al.
patent: 7141574 (2006-11-01), Beaulieu et al.
patent: 7157486 (2007-01-01), Beaulieu et al.
patent: 2003/0176433 (2003-09-01), Beaulieu, et al.
patent: 2004/0110126 (2004-06-01), Kukolj, et al.
patent: 2004/0171626 (2004-09-01), Beaulieu et al.
patent: 2004/0224955 (2004-11-01), Beaulieu, et al.
patent: 2 412 718 (2002-01-01), None
patent: 2 448 737 (2003-01-01), None
patent: 2 449 180 (2003-02-01), None
patent: WO 2004/065367 (2004-08-01), None
Kolykhalov, et al. J. Virology, 2000, 74(4): 2046-51.
Beaulieu Pierre
Brochu Christian
Kawai Stephen
Rancourt Jean
Stammers Timothy A.
Baker Michael P.
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Dow David
Morris Michael
LandOfFree
Viral polymerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral polymerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral polymerase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3816830